4-aminoimidazole has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
4-aminoimidazole: structure in first source
4-aminoimidazole : An aminoimidazole that is 1H-imidazole substituted by an amino group at position 4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tripathi, V | 1 |
| Jaiswal, P | 1 |
| Assaiya, A | 1 |
| Kumar, J | 1 |
| Parmar, HS | 1 |
1 other study available for 4-aminoimidazole and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Anti-cancer Effects of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside (AICAR) on Triple-negative Breast Cancer (TNBC) Cells: Mitochondrial Modulation as an Underlying Mechanism.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Doxorubicin; Humans; Imidazoles; Mitochon | 2022 |